Article
Cutaneous leishmaniasis: therapeutic strategies and future directions.
Expert opinion on pharmacotherapy - 1 Nov 2007
Ameen Mahreen
Abstract excerpt
Cutaneous leishmaniasis is a major tropical infection caused by vector-borne protozoa of the Leishmania species. Disease presentation, clinical course, prognosis and response to therapy is species- and geographic region-dependent. A wide variety of treatment modalities exist for the diverse spectrum of clinical disease. Traditional antileishmanial systemic agents such as antimonials, pentamidine and amphotericin...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
